LANXESS Aktiengesellschaft (ETR:LXS)

Market Cap	1.40B -39.8%
Revenue (ttm)	5.45B -14.3%
Net Income	-661.00M
EPS	-7.66
Shares Out	86.35M
PE Ratio	n/a
Forward PE	23.28
Dividend	0.10 (0.62%)
Ex-Dividend Date	May 22, 2026

Volume	584,762
Open	16.18
Previous Close	16.25
Day's Range	16.18 - 17.19
52-Week Range	11.03 - 27.68
Beta	1.16
Analysts	Hold
Price Target	17.56 (+5.4%)
Earnings Date	May 7, 2026

About ETR:LXS

LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the ag...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1863
• Employees: 11,630
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: LXS

Financial Performance

In 2025, ETR:LXS's revenue was 5.67 billion, a decrease of -10.89% compared to the previous year's 6.37 billion. Losses were -577.00 million, 226.0% more than in 2024.

Analyst Summary

According to 16 analysts, the average rating for LXS stock is "Hold." The 12-month stock price target is €17.56, which is an increase of 5.40% from the latest price.

Price Target

€17.56

(5.40% upside)

Analyst Consensus: Hold